-
Prognostic Impact of Advanced Lung Cancer Inflammation Index (ALI) on Immunotherapy Outcomes in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter Post Hoc Analysis
08 Oct 2025 06:55 GMT
… systemic inflammation. The Advanced Lung Cancer Inflammation Index (ALI … S, et al. Gemcitabine plus cisplatin versus fluorouracil … and advanced lung cancer inflammation index (ALI). Transl Lung Cancer Res. … mature neutrophils in lung cancer tissues impairs the …
-
Verastem Oncology Announces Updated Data from Partner GenFleet Therapeutics’ Phase 1/2 Monotherapy Study in China of GFH375 (VS-7375) in Advanced KRAS G12D Mutant Pancreatic Ductal Adenocarcinoma
19 Oct 2025 09:15 GMT
… 92.4% of patients receiving gemcitabine-based regimens and more than … , colorectal, and non-small cell lung cancers.
About the GenFleet Therapeutics Collaboration …
-
Trodelvy® Reduces Risk of Disease Progression or Death by 38% Versus Chemotherapy as First-Line Therapy in Patients With Metastatic Triple-Negative Breast Cancer in ASCENT-03 Study
19 Oct 2025 09:15 GMT
… physician’s choice, which included gemcitabine plus carboplatin, paclitaxel, or nab … than 90% of breast and lung cancers. Trodelvy is intentionally designed with …
-
Dermatotoxicity of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: Current Advances in Mechanistic Insights and Predictive Biomarker Identification
17 Sep 2025 09:09 GMT
… cells are enriched in lung tumors and inflammatory lung … -small cell lung cancer treated with nivolumab. Lung Cancer. 2019;132 … non-small cell lung cancer (NSCLC). Transl Lung Cancer Res. 2021; … combination with cisplatin plus gemcitabine in Japanese patients …
-
Emerging Targets in Non-Small Cell Lung Cancer
06 Sep 2025 06:12 GMT
… lung cancer (NSCLC) represents approximately 85% of all lung cancer … /ramucirumab, docetaxel, gemcitabine, and pemetrexed) in patients … non-small cell lung cancer: molecular mechanisms and … advanced non-small cell lung cancer. Lung Cancer. 2023;182:107291. …
-
HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and the CSCO Annual Meeting 2025
05 Sep 2025 00:00 GMT
… 2025 World Conference on Lung Cancer (“WCLC”) taking place … in non-small cell lung cancer (“NSCLC”) patients will … 22
Poster: Small Cell Lung Cancer and Neuroendocrine Tumors
Tuesday, … of surufatinib combined with gemcitabine, cisplatin and immune checkpoint …
-
<![CDATA[Durvalumab Plus Chemotherapy Sets New Standard in Resectable Gastric and GEJ Cancer]]>
18 Oct 2025 00:57 GMT
… with limited-stage small cell lung cancer whose disease has not progressed … received a second approval with gemcitabine and cisplatin as neoadjuvant treatment …
-
Comparison of the Efficacy of Immune Checkpoint Inhibitors Combined with Chemotherapy Versus Bevacizumab Combined with Chemotherapy in Advanced Driver Gene-Negative Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study
28 Jul 2025 23:36 GMT
… cell lung cancer transformed into small-cell lung cancer after treatment … non-small cell lung cancer: clinical outcomes and … lung cancer patients with malignant pleural effusion. Transl Lung Cancer Res … of combination of gemcitabine and nedaplatin for …
-
Predictive Value of Tumor ERCC1 Expression for Treatment Outcomes After Adjuvant Chemotherapy in Patients with Completely Resected Non-Small Cell Lung Cancer
19 Jul 2025 11:24 GMT
… : non-small cell lung cancer, postoperative adjuvant chemotherapy, … small-cell lung cancer treated with cisplatin and gemcitabine. Ann … resected non-small cell lung cancer. Lung Cancer. 2008;62(1 … -based concurrent chemoradiotherapy. Lung Cancer. 2010;68(2 …
-
A Systematic Review of SNPs Screening for Platinum-Related Pharmacodynamics and Pharmacokinetics Genes in Non-Small Cell Lung Cancer for Precision Medicine
26 Jun 2025 22:33 GMT
… cell lung cancer receiving first-line platinum-gemcitabine chemotherapy … lung cancer patients treated with platinum-based chemotherapy. Lung Cancer … -small cell lung cancer patients. Lung Cancer. 2011;72 … lung cancer: 2009 looking toward 2012. Chin J Lung Cancer …